Skip to main content

D. E. Shaw & Co., Inc.

Position in PCVX — Vaxcyte, Inc.

CIK 1009207 New York, NY

Position in PCVX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$110,555,819
-$55,947,809 QoQ
Shares Held
1,901,872
-33.6% QoQ
Ownership
1.28%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#18
of 329 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PCVX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. PCVX ranks #11 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PCVX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $110,555,819 1,901,872
2026-03-31 $166,503,628 2,865,318
2025-12-31 $167,536,785 3,631,053
2025-09-30 $154,554,255 4,290,790
2025-06-30 $100,405,509 3,088,450
2025-03-31 $32,771,564 867,891
2024-12-31 $63,494,954 775,653
2024-09-30 $48,393,116 423,498
2024-06-30 $17,382,930 230,207
2024-03-31 $25,086,779 367,249
2023-12-31 $27,525,930 438,311
2023-09-30 $27,446,816 538,384
2023-06-30 $40,596,824 812,912
2023-03-31 $29,793,114 794,907
2022-12-31 $46,622,791 972,321